Effects of Acute and Subchronic Δ9-tetrahydrocannabinol Administration on the Plasma Catecholamine, β-Endorphin, and Corticosterone Levels and Splenic Natural Killer Cell Activity in Rats

Abstract The effect of acute (1 day) or subchronic (25 days) treatment with Δ9-tetrahydrocannabinol (THC), the major psychoactive constituent of marihuana, on plasma norepinephrine (NE), epinephrine (E), corticosterone, β-endorphin (β-end), and splenic natural killer (NK) cell activity of the rat was studied. Groups of animals received subcutaneously, either THC in corn oil + saline (3 mg THC/kg); oil + saline: or THC + naloxone (2 mg naloxone/kg and 3 mg THC/kg). Acute injection of THC with or without naloxone did not significantly change plasma levels of NE, E corticosterone, β-end, or the NK cell activity. However, subchronic treatment with THC significantly reduced plasma levels of NE, E, corticosterone, and NK cell activity, compared to controls. The plasma β-end levels were significantly elevated in the THC-treated animals. In the THC + naloxone group of animals, the plasma hormone levels (corticosterone and β-end) were similar to control levels and the NK cell activity was significantly higher than in THC-treated animals. These results indicate that subchronic exposure to THC results in suppression of splenic NK cell activity. The interaction of THC with the endogenous opiate system appears to be a contributing factor leading to the NK cell suppression in rats. A direct suppressive action of THC or its metabolites on the NK cell is not ruled out by this study.

[1]  R. Schiavi,et al.  Influence of brain and behavior on the immune system. , 2003, Science.

[2]  M. Borysenko,et al.  Effect of Δ 9-THC on brain and plasma catecholamine levels as measured by HPLC , 1985, Brain Research Bulletin.

[3]  C. Froelich,et al.  The effect of β-endorphin on natural cytotoxicity and antibody dependent cellular cytotoxicity , 1984 .

[4]  J. Morley,et al.  Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. , 1984, Life sciences.

[5]  R. Faith,et al.  Neuroimmunomodulation with enkephalins: enhancement of human natural killer (NK) cell activity in vitro. , 1984, Clinical immunology and immunopathology.

[6]  Y. Shavit,et al.  Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. , 1984, Science.

[7]  C. Froelich,et al.  Enhancement of natural cytotoxicity by beta-endorphin. , 1983, Journal of immunology.

[8]  N. Holbrook,et al.  Suppression of the Natural Killer Cell Activity of Murine Spleen Cell Cultures by Dexamethasone , 1982, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[9]  I. Lamster,et al.  Beta-endorphin modulates human immune activity via non-opiate receptor mechanisms. , 1982, Life sciences.

[10]  M. Borysenko,et al.  Stress, behavior, and immunity: animal models and mediating mechanisms. , 1982, General hospital psychiatry.

[11]  A. Bloom Effect of delta9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synaptosomes. , 1982, The Journal of pharmacology and experimental therapeutics.

[12]  K. Oshimi,et al.  Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus. , 1980, Clinical and experimental immunology.

[13]  P. Cuatrecasas,et al.  Specific nonopiate receptors for beta-endorphin. , 1979, Science.

[14]  J. Jacobs,et al.  The effects of Δ9‐tetrahydrocannabinol, cannabidiol, and shock on plasma corticosterone concentrations in rats , 1979, The Journal of pharmacy and pharmacology.

[15]  G. Nahas,et al.  Plasma membrane inhibition of macromolecular precursor transport by THC. , 1979, Biochemical pharmacology.

[16]  T. Duka,et al.  Distribution of methionine- and leucine-enkephalin within the rat pituitary gland measured by highly specific radioimmunoassays. , 1978, Biochemical and biophysical research communications.

[17]  F. Bloom,et al.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. , 1977, Science.

[18]  G. Nahas,et al.  Effects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes. , 1977, Federation proceedings.

[19]  A. Mellors,et al.  Delta-9 -tetrahydrocannabinol and decreased macrophage migration inhibition activity. , 1975, Research communications in chemical pathology and pharmacology.

[20]  J. Sprent,et al.  Interaction between lymphocytes in immune responses. , 1971, Cellular immunology.

[21]  J. Idänpään-Heikkilä,et al.  Distribution of Marihuana in Monkey Brain and Concomitant Behavioural Effects , 1971, Nature.

[22]  L. Harris,et al.  The effect of 1-trans-delta 9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats. , 1970, European journal of pharmacology.

[23]  D. B. Duncan MULTIPLE RANGE AND MULTIPLE F TESTS , 1955 .

[24]  G. Nahas,et al.  DISTRIBUTION AND DISPOSITION OF DELTA-9-TETRAHYDROCANNABINOL (THC) IN DIFFERENT TISSUES OF THE RAT , 1984 .

[25]  C. L. Chen,et al.  Effect of an acute dose of delta 9-THC on hypothalamic luteinizing hormone releasing hormone and met-enkephalin content and serum levels of testosterone and corticosterone in rats. , 1983, Substance and alcohol actions/misuse.

[26]  Y. K. Luthra,et al.  Assessment of tolerance to immunosuppressive activity of delta 9-tetrahydrocannabinol in rats. , 1980, Journal of immunopharmacology.

[27]  E. Sorkin,et al.  Immunoregulation mediated by the sympathetic nervous system. , 1979, Cellular immunology.

[28]  A. Mellors Cannabinoids and membrane-bound enzymes. , 1978, Advances in the biosciences.

[29]  I. Cameron,et al.  delta1-tetrahydrocannabinol, cannabidiol and cannabinol effects on the immune response of mice. , 1977, Pharmacology.

[30]  H. Rosenkrantz The Immune Response and Marihuana , 1976 .